It is a paper private limited company based in Kolkata, West Bengal, India, established in 2025.
2025 | Kolkata, West Bengal, India | ActiveElixacell Therapeutics Private Limited, a active private limited company, was established on 25 February 2025 in Kolkata, West Bengal, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000WB2025PTC276831. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Raushan Kumar Sinha (Director), Supriya Sadhukhan (Director). It is based at 13E, Santosh Roy Road,, South 24 Parganas,, Kolkata, West Bengal, 700008.
U21000WB2025PTC276831
276831
25 February 2025
₹0.10 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Elixacell Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raushan Kumar Sinha | Director | 25 Feb 2025 | Current |
| Supriya Sadhukhan | Director | 25 Feb 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Elixacell Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elixacell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elixacell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixacell Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Raushan Kumar Sinha was appointed as a Director was appointed as a Director on 25 Feb 2025 & has been associated with this company since 9 months 22 days . was recorded as a recent event.
Supriya Sadhukhan was appointed as a Director was appointed as a Director on 25 Feb 2025 & has been associated with this company since 9 months 22 days . was recorded as a recent event.
The activity Elixacell Therapeutics Private Limited was registered on 25 Feb 2025 with Roc Kolkata & aged 9 months 22 days as per MCA records. was completed.
The CIN of Elixacell Therapeutics Private Limited is U21000WB2025PTC276831.
Elixacell Therapeutics Private Limited is headquartered at 13E, Santosh Roy Road,, South 24 Parganas,, Kolkata, West Bengal, 700008.
Elixacell Therapeutics Private Limited was incorporated on 25 February 2025.
The current directors of Elixacell Therapeutics Private Limited are
The primary industry of Elixacell Therapeutics Private Limited is Paper.
Elixacell Therapeutics Private Limited is unlisted.
The authorized capital of Elixacell Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX